Paralysis News and Research

RSS
Paralysis is the loss of muscle function in part of your body. It happens when something goes wrong with the way messages pass between your brain and muscles. Paralysis can be complete or partial. It can occur on one or both sides of your body. It can also occur in just one area, or it can be widespread. Paralysis of the lower half of your body, including both legs, is called paraplegia. Paralysis of the arms and legs is quadriplegia.
New blood test achieves 98% accuracy in diagnosing ALS

New blood test achieves 98% accuracy in diagnosing ALS

New target identified for potential ALS therapy

New target identified for potential ALS therapy

COVID-19 linked to increased risk of hearing loss in young adults, study finds

COVID-19 linked to increased risk of hearing loss in young adults, study finds

Calls for humanitarian pause to safeguard polio vaccination efforts in Gaza

Calls for humanitarian pause to safeguard polio vaccination efforts in Gaza

CDC study reveals significantly higher Lyme disease rates among older adults than previously reported

CDC study reveals significantly higher Lyme disease rates among older adults than previously reported

Stretching vs. meditation: New study finds both practices reduce nocturnal muscle cramps in cirrhosis patients

Stretching vs. meditation: New study finds both practices reduce nocturnal muscle cramps in cirrhosis patients

Researchers identify key genetic players in dopamine signaling using transparent worms                                           With The Help Of A Tin...

Researchers identify key genetic players in dopamine signaling using transparent worms With The Help Of A Tin...

Surgery improves long-term outcomes for T-OPLL

Surgery improves long-term outcomes for T-OPLL

Breakthrough MS drug uses green mamba venom discovery to promote myelin repair

Breakthrough MS drug uses green mamba venom discovery to promote myelin repair

ACE technology enhances single-cell protein detection with advanced signal amplification

ACE technology enhances single-cell protein detection with advanced signal amplification

Motor neurone disease research receives major boost through new data catalyst initiative

Motor neurone disease research receives major boost through new data catalyst initiative

Scientists explore early life factors contributing to SMA

Scientists explore early life factors contributing to SMA

Breakthrough therapy heals spinal cord injuries

Breakthrough therapy heals spinal cord injuries

UK initiative aims to transform MND research through health data collaboration

UK initiative aims to transform MND research through health data collaboration

Concussions in retired rugby players linked to higher neurodegenerative disease biomarkers

Concussions in retired rugby players linked to higher neurodegenerative disease biomarkers

New threshold for CXCL13 concentration revolutionizes neuroborreliosis diagnosis

New threshold for CXCL13 concentration revolutionizes neuroborreliosis diagnosis

Understanding the platelet-monocyte interaction to improve treatment of immune disorders

Understanding the platelet-monocyte interaction to improve treatment of immune disorders

Gene therapy milestone at SickKids offers hope for children with SPG50 neurodegenerative disorder

Gene therapy milestone at SickKids offers hope for children with SPG50 neurodegenerative disorder

Moderate physical activity may be linked to reduced risk of ALS later in life

Moderate physical activity may be linked to reduced risk of ALS later in life

Innovative CAR T cell therapy shows promise for relapsed CIDP patients

Innovative CAR T cell therapy shows promise for relapsed CIDP patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.